The EMJ is a specialist publisher who combines leading editorials from key opinion leaders with a concise news coverage from the leading congresses within the industry, delivering world-class insights to the key developments and advancements …

Mar 10, 2025 · NEW global guidelines have been developed to improve the management of Candida infections, addressing emerging antifungal resistance, recent taxonomic reclassifications, and gaps in existing treatment recommendations. Led by the European Confederation for Medical Mycology (ECMM) in collaboration with international mycological societies, these guidelines provide updated diagnostic and ...

Mar 3, 2025 · NEW findings presented at the ACTRIMS Forum 2025 highlight how the latest revisions to the McDonald Criteria could reshape the diagnosis of multiple sclerosis (MS), allowing for earlier identification in patients with radiologically isolated …

Mar 11, 2025 · Preliminary results from the MITO 40 study presented at ESGO 2025 suggest Niraparib as a promising maintenance treatment for ovarian cancer patients with no residual disease after primary surgery.

Mar 11, 2025 · Updated data from the ATHENA-MONO study, presented at ESGO 2025 Annual Meeting, has confirmed that rucaparib, a maintenance treatment, continues to provide significant post-progression survival benefits for patients with newly diagnosed advanced high-grade ovarian cancer (HGOC).

If you’ve explored the EMJ website, and haven’t found the answer you’re looking for, or if you need any help, please do contact us.

Jan 16, 2025 · This three-part podcast series “Invasive Meningococcal Disease Prevention,” hosted by Hannah Moir leads a discussion with key experts Burkhard Lawrenz, Catherine Weil-Olivier, Irene Rivero Calle, and Susanna Esposito who cover a peer-to-peer perspective on the importance of preventing invasive meningococcal disease (IMD).

What challenges does pharma face? Despite their success, field medical teams face significant barriers to engaging KOLs. Understanding and addressing these hurdles is critical to becoming best in class.

Feb 13, 2025 · GROUNDBREAKING research has found that microplastics are accumulating in human brains at alarming levels, with concentrations increasing over time and potentially linked to dementia.

Mar 11, 2025 · A RANDOMISED clinical trial has found that low-dose semaglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist, reduces alcohol craving and some measures of alcohol consumption in adults with alcohol use disorder (AUD), supporting the need for larger trials to explore its potential as a treatment.. Alcohol use disorder is a chronic condition characterised by excessive alcohol consumption ...